FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2147429429> ?p ?o ?g. }

• W2147429429 endingPage "252" @default.
• W2147429429 startingPage "247" @default.
• W2147429429 abstract "Background: With poor cure rates in gastric cancer using surgery alone, the safety, efficacy and feasibility of preoperative and postoperative chemotherapy was investigated. Methods: Patients with advanced but operable gastric or cardio‐oesophageal adenocarcinoma were staged using endoscopy, computed tomography scan and laparoscopy. If considered potentially resectable, they received chemotherapy (epirubicin, cisplatin and 5‐fluorouracil) for 9 weeks before and after surgery. Results: Of 59 participants entered, two were found to have metastatic disease and were excluded from the analysis. Of the participants, 10 were women and 47 men; their median age was 58 years (range 27–83 years) and median performance status 0 (range 0–1). Two of the 57 participants commencing chemotherapy did not undergo surgery (one sudden death, one new liver metastases). Grade 3 and 4 preoperative and postoperative toxicity rates were, respectively, neutropenia 22 and 18%, emesis 12 and 14% and other non‐haematological toxicity <10 and <10%. Of the 55 who underwent surgery, 40 had apparently curative resections (clear or positive microscopic margins), 2 died after surgery (anastomotic leak, sepsis) and 16 had postoperative complications. Of these, 27 participants commenced postoperative chemotherapy and 21 completed it. Median progression‐free survival and overall survival were 19.6 and 22 months, respectively. Conclusion: Epirubicin, cisplatin and protracted venous infusion of 5‐fluorouracil chemotherapy was well‐tolerated in the preoperative setting and did not appear to increase complication rates of surgery for advanced and operable stomach cancer. These findings demonstrate the feasibility of this strategy in the Australasian clinical setting and are in keeping with the results of a recently reported randomized trial, which demonstrated a significant survival advantage using this chemotherapy regimen." @default.
• W2147429429 created "2016-06-24" @default.
• W2147429429 creator A5009045936 @default.
• W2147429429 creator A5010965225 @default.
• W2147429429 creator A5011795261 @default.
• W2147429429 creator A5012382701 @default.
• W2147429429 creator A5012817368 @default.
• W2147429429 creator A5017072034 @default.
• W2147429429 creator A5034608948 @default.
• W2147429429 creator A5038662782 @default.
• W2147429429 creator A5043328353 @default.
• W2147429429 creator A5046678435 @default.
• W2147429429 creator A5051942976 @default.
• W2147429429 creator A5055663436 @default.
• W2147429429 creator A5062026972 @default.
• W2147429429 creator A5077480826 @default.
• W2147429429 creator A5078462142 @default.
• W2147429429 creator A5082235252 @default.
• W2147429429 date "2007-03-27" @default.
• W2147429429 modified "2023-10-18" @default.
• W2147429429 title "A PILOT STUDY OF PREOPERATIVE AND POSTOPERATIVE CHEMOTHERAPY IN PATIENTS WITH OPERABLE GASTRIC CANCER: AUSTRALASIAN GASTROINTESTINAL TRIALS GROUP STUDY 9601" @default.
• W2147429429 cites W1558888202 @default.
• W2147429429 cites W1843791750 @default.
• W2147429429 cites W1934342468 @default.
• W2147429429 cites W1987653325 @default.
• W2147429429 cites W1991207916 @default.
• W2147429429 cites W2022413725 @default.
• W2147429429 cites W2024538562 @default.
• W2147429429 cites W2026986976 @default.
• W2147429429 cites W2044889252 @default.
• W2147429429 cites W2085118973 @default.
• W2147429429 cites W2095256813 @default.
• W2147429429 cites W2099433579 @default.
• W2147429429 cites W2101744898 @default.
• W2147429429 cites W2111513457 @default.
• W2147429429 cites W2115072149 @default.
• W2147429429 cites W2143863553 @default.
• W2147429429 cites W2167805334 @default.
• W2147429429 cites W2944924994 @default.
• W2147429429 cites W4255483444 @default.
• W2147429429 doi "https://doi.org/10.1111/j.1445-2197.2007.04027.x" @default.
• W2147429429 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17388828" @default.
• W2147429429 hasPublicationYear "2007" @default.
• W2147429429 type Work @default.
• W2147429429 sameAs 2147429429 @default.
• W2147429429 citedByCount "4" @default.
• W2147429429 countsByYear W21474294292014 @default.
• W2147429429 crossrefType "journal-article" @default.
• W2147429429 hasAuthorship W2147429429A5009045936 @default.
• W2147429429 hasAuthorship W2147429429A5010965225 @default.
• W2147429429 hasAuthorship W2147429429A5011795261 @default.
• W2147429429 hasAuthorship W2147429429A5012382701 @default.
• W2147429429 hasAuthorship W2147429429A5012817368 @default.
• W2147429429 hasAuthorship W2147429429A5017072034 @default.
• W2147429429 hasAuthorship W2147429429A5034608948 @default.
• W2147429429 hasAuthorship W2147429429A5038662782 @default.
• W2147429429 hasAuthorship W2147429429A5043328353 @default.
• W2147429429 hasAuthorship W2147429429A5046678435 @default.
• W2147429429 hasAuthorship W2147429429A5051942976 @default.
• W2147429429 hasAuthorship W2147429429A5055663436 @default.
• W2147429429 hasAuthorship W2147429429A5062026972 @default.
• W2147429429 hasAuthorship W2147429429A5077480826 @default.
• W2147429429 hasAuthorship W2147429429A5078462142 @default.
• W2147429429 hasAuthorship W2147429429A5082235252 @default.
• W2147429429 hasConcept C121608353 @default.
• W2147429429 hasConcept C126322002 @default.
• W2147429429 hasConcept C141071460 @default.
• W2147429429 hasConcept C2776694085 @default.
• W2147429429 hasConcept C2776755627 @default.
• W2147429429 hasConcept C2777063308 @default.
• W2147429429 hasConcept C2780835546 @default.
• W2147429429 hasConcept C71924100 @default.
• W2147429429 hasConceptScore W2147429429C121608353 @default.
• W2147429429 hasConceptScore W2147429429C126322002 @default.
• W2147429429 hasConceptScore W2147429429C141071460 @default.
• W2147429429 hasConceptScore W2147429429C2776694085 @default.
• W2147429429 hasConceptScore W2147429429C2776755627 @default.
• W2147429429 hasConceptScore W2147429429C2777063308 @default.
• W2147429429 hasConceptScore W2147429429C2780835546 @default.
• W2147429429 hasConceptScore W2147429429C71924100 @default.
• W2147429429 hasIssue "4" @default.
• W2147429429 hasLocation W21474294291 @default.
• W2147429429 hasLocation W21474294292 @default.
• W2147429429 hasOpenAccess W2147429429 @default.
• W2147429429 hasPrimaryLocation W21474294291 @default.
• W2147429429 hasRelatedWork W1988281091 @default.
• W2147429429 hasRelatedWork W1999547891 @default.
• W2147429429 hasRelatedWork W2010069207 @default.
• W2147429429 hasRelatedWork W2041554215 @default.
• W2147429429 hasRelatedWork W2084016080 @default.
• W2147429429 hasRelatedWork W2092331566 @default.
• W2147429429 hasRelatedWork W2168662668 @default.
• W2147429429 hasRelatedWork W2306618277 @default.
• W2147429429 hasRelatedWork W2371360806 @default.
• W2147429429 hasRelatedWork W4241240326 @default.
• W2147429429 hasVolume "77" @default.
• W2147429429 isParatext "false" @default.
• W2147429429 isRetracted "false" @default.

• next